Sage Journals: Discover world-class research

Retricted access

Research article

First published 2014-3

Reverse-Payment Patent Settlements in the Pharmaceutical Industry: An Analysis of U.S. Antitrust Law and EU Competition Law

Michael Clancy, Damien Geradin, Andrew Lazerow

The Antitrust Bulletin

Retricted access

Research article

First published 2012-5

Current trend in pharmaceutical law in EU

María Dolores Cabezas

Pharmaceuticals Policy and Law

Open access

Research article

First published 2020-6

Public Interest and EU Competition Law

Niamh Dunne

The Antitrust Bulletin

Retricted access

Research article

First published 2018-12

Pharmaceutical products liability in Poland

Piotr Machnikowski

Pharmaceuticals Policy and Law

Retricted access

Research article

First published 2013-8

Orphan drugs and paediatric medicinal products

Franziska Sprecher

Pharmaceuticals Policy and Law

Retricted access

Research article

First published 2006-7

Wholesale trade in named-patient medicines in the EU: “Specials” and exempt imports

Julian Roberts

Pharmaceuticals Policy and Law

Retricted access

Research article

First published 2005-2

Four decades of European medicines regulation: What have they brought us?

John A. Lisman, J. Frits F. Lekkerkerker

International Journal of Risk & Safety in Medicine

Retricted access

Other

First published 2004-7

Review of the European Pharmaceutical Legislation

Susan De Stasio, Nadene McClay

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

Retricted access

Research article

First published 2006-7

The European Union's policy on medicinal products

José Luis Valverde

Pharmaceuticals Policy and Law

Retricted access

Research article

First published 2017-4

Illegal medicines as threats to public health

José Luis Valverde

Pharmaceuticals Policy and Law

Search results